Unique ID issued by UMIN | UMIN000029577 |
---|---|
Receipt number | R000033790 |
Scientific Title | Effect of test food consumption on tear secretion and physical condition. |
Date of disclosure of the study information | 2017/10/17 |
Last modified on | 2020/03/02 16:19:05 |
Effect of test food consumption on tear secretion and physical condition.
Effect of test food consumption on tear secretion and physical condition.
Effect of test food consumption on tear secretion and physical condition.
Effect of test food consumption on tear secretion and physical condition.
Japan |
Healthy adults
Ophthalmology |
Others
NO
To quantify the effect of continuous consumption of test food, which is cows' milk containing dietary fibers, on tear secretion and physical condition.
Safety,Efficacy
BUT, Schirmer's test, Questionnaire about ocular symptoms
Fecal microbiota, breath hydrogen concentration, oxidative-stress marker in tear, and questionnaire
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Subjects take 200mL test food every morning in daily life for 3 weeks.
Subjects take 200mL placebo every morning in daily life for 3 weeks.
20 | years-old | <= |
60 | years-old | >= |
Male and Female
1.Healthy adults
2.Subjects who feel eye dryness
1. Subjects under treatment of eyes
2. Subjects who operated or plan an operation for eyes within three months of screening test
3. Subjects who have serious or progressive illness and symptom
4. Subjects who routinely take pharmaceutical, quasi drug or health food, which may influence the result of this trial (including foods containing oligosaccharide, dietary fiber, hydrogen water and supplements that produce hydrogen gas)
5. Subjects who can avoid the intake of milk and dairy products except test food from screening examination to three weeks later
6. Subjects who have food allergies or drug allergies
7. Subjects with serious lactose intolerance (diarrhea)
8. Subjects who have serious constipation which need to take cathartic drugs and laxative products
9. Subjects under treatment of dry eye
10. Subjects who were enrolled in other trails within one month of screening test
11. Female Subjects who are or might become pregnant
12. Subjects who have history of serious hepatic disorder, renal damage, or myocardial infarction
13. Subjects who have been receiving drug treatment
14. Subjects with severe anemia
15. Inappropriate cases evaluated by doctors
50
1st name | Motoko |
Middle name | |
Last name | Kawashima |
Keio University School of Medicine
Department of Ophthalmology
160-8582
35, Shinanomachi, Shinjyuku-ku, Tokyo 160-8582
03-3353-1211
motoko-k@a3.keio.jp
1st name | Yoshitada |
Middle name | |
Last name | Hira |
imeQ CO. Ltd.
CRO division
169-0051
a vous primus Bld, 2-14-6, nishiwaseda, Shinjuku-ku, Tokyo 169-0075
03-6205-6222
y-hira@imeq.co.jp
Kyodo Milk Industry Co. Ltd.
Research Laboratories
Kyodo Milk Industry Co. Ltd.
Research Laboratories
Self funding
Iryouhoujinsyadan Hakusuikai Suda Clinical Institutional Review Board
2-8-14 Takadanobaba, Shinjuku-ku, Tokyo 169-0051, Japan
03-6205-6222
suda-clinic_irb@imeq.co.jp
NO
医療法人社団浩央会 国立さくら病院
2017 | Year | 10 | Month | 17 | Day |
Unpublished
Completed
2017 | Year | 10 | Month | 11 | Day |
2017 | Year | 10 | Month | 11 | Day |
2017 | Year | 10 | Month | 17 | Day |
2017 | Year | 12 | Month | 29 | Day |
2018 | Year | 02 | Month | 09 | Day |
2017 | Year | 10 | Month | 16 | Day |
2020 | Year | 03 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033790